# Copper Peptide Hair Growth: The GHK-Cu Hair Research, Plate by Plate

> Copper peptide hair growth research: a 6-month trial raised hair count by up to 71.5 versus 9.6 for placebo, and a mouse microemulsion drove follicles into anagen by day 6. The GHK-Cu hair record, cited and weighed.

From C3H mice to a 45-patient randomized trial — the copper-peptide hair evidence set out as engraved plates, with the combination-formulation caveat kept in plain view.

## What the hair-growth record actually shows

Copper peptide hair growth research is older than most readers expect and stronger in animals than in humans. The earliest plate is from 1991: peptide-copper complexes stimulated hair-follicle activity and growth in C3H mice, establishing the preclinical basis for copper peptides in hair [7]. The headline human result is a 6-month randomized trial in 45 men with androgenetic alopecia (Norwood-Hamilton II-V): a topical complex of 5-aminolevulinic acid and glycyl-histidyl-lysine peptide increased hair count by 52.6 (100 mg/mL) and 71.5 (50 mg/mL) versus 9.6 for placebo (p<0.05), with no adverse events in any group [4].

One caveat governs everything on this page: that trial tested a combination formulation (5-ALA plus a GHK peptide), not pure GHK-Cu. It is the strongest controlled human efficacy signal for a GHK-containing topical, and it is genuinely positive — but attributing the full hair-count gain to the copper peptide alone would overstate what the study isolated. The honest reading is: a GHK-containing topical beat placebo in a small RCT, and copper-peptide mechanism plausibly contributes.

## Do copper peptides stimulate hair growth?

In a 6-month trial of 45 men with androgenetic alopecia, a topical 5-aminolevulinic-acid + glycyl-histidyl-lysine complex increased hair count by 52.6 (100 mg/mL) and 71.5 (50 mg/mL) versus 9.6 for placebo (p<0.05) [4]; preclinical mouse and follicle models report extended anagen and dermal-papilla proliferation [7]. The human result is from one small combination-formulation trial, so it is research-stage evidence, not a treatment claim.

## Does copper peptide regrow hair?

A 2% GHK-Cu ionic-liquid microemulsion drove mouse follicles into anagen within 6 days (versus 9 for minoxidil) with higher hair density at 28 days and no change in testosterone or estradiol [14]; the strongest human signal is the 45-patient combination-formulation trial that beat placebo over 6 months [4]. 'Regrow' is supported in the animal model and suggested in the small human trial — see the full [does copper peptide regrow hair](/hair-research) evidence below.

## Does copper peptide work for hair growth?

Research models report VEGF-driven follicular angiogenesis, collagen and glycosaminoglycan synthesis and anagen induction [6][14]; controlled human data are limited to one 45-patient combination-formulation RCT [4], so results are research-stage, not a treatment claim. 'Works' is well supported mechanistically and in animals, and supported in one small human trial of a combination product.

## The non-androgenic mechanism

The studied copper-peptide hair mechanism is non-androgenic, which is its most distinctive feature against most hair-loss research. In the mouse ionic-liquid-microemulsion study, follicles entered anagen via Wnt/beta-catenin, VEGF and HGF signaling with no change in testosterone or estradiol [14]. That separates copper peptides mechanistically from DHT-pathway inhibitors: the proposed route is follicular angiogenesis and dermal-papilla support, not androgen blockade [6].

The ex-vivo work fills in the cellular detail through a close analog. A tripeptide-copper complex, AHK-Cu — the alanyl analog of GHK-Cu — at 10^-12 to 10^-9 M stimulated elongation of human hair follicles and proliferation of dermal papilla cells, and at 10^-9 M reduced apoptosis (higher Bcl-2/Bax ratio, lower cleaved caspase-3 and PARP) [8]. We cite this strictly as analog context: it tested AHK-Cu, not GHK-Cu, so it illustrates the copper-tripeptide follicle mechanism without standing in as GHK-Cu efficacy.

## Is copper a DHT blocker?

No. The studied copper-peptide hair mechanism is non-androgenic: a mouse study reported follicle anagen via Wnt/beta-catenin, VEGF and HGF with no change in testosterone or estradiol [14], distinct from DHT-pathway inhibitors. Copper peptides are studied as follicular-support agents, not as androgen-axis blockers.

## How long does GHK-Cu take to regrow hair?

Timelines come from study endpoints, not dosing guidance: a mouse microemulsion study saw anagen entry by day 6 and greater density by day 28 [14], and the human ALAVAX-type trial measured hair-count gains over 6 months [4]. These are the windows at which studies measured outcomes, not a predicted personal timeline.

## How long do copper peptides take to work on hair?

In the cited preclinical model, follicles re-entered the active growth (anagen) phase within about 6 days and density increased by 28 days [14]; the controlled human trial measured outcomes at 6 months [4]. Animal timelines are faster than human-trial endpoints, and neither is a usage schedule.

## Where the hair evidence stops

The hair literature is encouraging and incomplete. The strongest human trial is small (n=45) and tested a combination product [4]; the mechanism evidence is animal and ex-vivo [7][8][14]; and the dermal-papilla detail comes from an analog, not GHK-Cu itself [8]. There is no large, long-duration, pure-GHK-Cu hair RCT in the peer-reviewed record.

That is the honest shape of it: a non-androgenic follicle mechanism with reproducible animal support and one positive small human combination trial. The native-delivery problem also applies here — free GHK's hydrophilicity (clogP -2.24) is why hair studies lean on microemulsions, microneedle pretreatment and other delivery systems to get the peptide to the follicle [13]. For tolerability questions, see our [copper peptide side effects](/side-effects) record.

---

An apothecary's folio of the GHK-Cu copper-tripeptide literature — each collagen assay, hair-count delta and stability constant set out as an engraved plate and weighed against its source, with no dispensary behind the counter and nothing here to dispense.